The World Stem Cell Summit will be co-located for the first time with the # 1 global industry event the Phacilitate Leadership Forum
Cell and Gene Therapy World, Immuno - Oncology Frontiers World, and Cord Blood and Perinatal Stem Cells.
Not exact matches
«The event, the fourth of its kind, seeks to raise global awareness
and create a forum for collaboration around the wide array of powerful
and promising
cell therapies,
gene therapies,
and immunotherapies emerging from medical institutions around the
world, as well as the impact new technology will have on humanity
and society,» a press release by the Cure Foundation explains (h / t Christian Post).
This year the WSCS will be co-located with the industry's premier partnering event; Phacilitate
World Leaders Forum, incorporating
Cell &
Gene Therapy World, Immuno - Oncology Frontiers
World,
and our shared Cord Blood & Perinatal Stem
Cells track.
Data from this trial was previously presented at
World Advanced
Therapies and Regenerative Medicine (May 17 - 19,2017; London, UK)
and the 20th Annual Meeting American Society of
Gene and Cell Therapy (ASGCT, May 10 - 13, 2017; DC, USA).
World Stem
Cell Summit
and Phacilitate are proud to present a the 3 - day EMERGING SCIENCE track covering ONCOLOGY, TRANSLATIONAL & CLINICAL UPDATE
and GENE THERAPY FOR RARE DISEASES.
Although it was not surprising for
cell and gene therapies per se, the growth that we have seen in this industry has been pretty dramatic around the
world as well.
This special event is shared between Phacilitate
Cell & Gene Therapy World and World Stem Cell Summit agendas, ensuring a unique audience made up of both industry and academic stakeholders as well as investors, big pharma, regulators and, of course, the world's leading cell and tissue ba
Cell &
Gene Therapy World and World Stem Cell Summit agendas, ensuring a unique audience made up of both industry and academic stakeholders as well as investors, big pharma, regulators and, of course, the world's leading cell and tissue b
World and World Stem Cell Summit agendas, ensuring a unique audience made up of both industry and academic stakeholders as well as investors, big pharma, regulators and, of course, the world's leading cell and tissue b
World Stem
Cell Summit agendas, ensuring a unique audience made up of both industry and academic stakeholders as well as investors, big pharma, regulators and, of course, the world's leading cell and tissue ba
Cell Summit agendas, ensuring a unique audience made up of both industry
and academic stakeholders as well as investors, big pharma, regulators
and, of course, the
world's leading cell and tissue b
world's leading
cell and tissue ba
cell and tissue banks.
World Stem
Cell Summit and Phacilitate Cell & Gene Therapy World is the only event to showcase the global cord blood and perinatal stem cell field while at the same time placing it in its broader strategic context as a critically important component of future cell, gene and immunotherapy business and production mod
Cell Summit
and Phacilitate
Cell & Gene Therapy World is the only event to showcase the global cord blood and perinatal stem cell field while at the same time placing it in its broader strategic context as a critically important component of future cell, gene and immunotherapy business and production mod
Cell &
Gene Therapy World is the only event to showcase the global cord blood and perinatal stem cell field while at the same time placing it in its broader strategic context as a critically important component of future cell, gene and immunotherapy business and production mod
Gene Therapy World is the only event to showcase the global cord blood
and perinatal stem
cell field while at the same time placing it in its broader strategic context as a critically important component of future cell, gene and immunotherapy business and production mod
cell field while at the same time placing it in its broader strategic context as a critically important component of future
cell, gene and immunotherapy business and production mod
cell,
gene and immunotherapy business and production mod
gene and immunotherapy business
and production models.
Focused on meeting this urgent unmet medical need, ALS TDI executes a robust target discovery program, while simultaneously operating the
world's largest efforts to preclinically validate potential therapeutics; including a pipeline of dozens of small molecules, protein biologics,
gene therapies and cell - based constructs.